First human test for new Alzheimer's drug candidate
NCT ID NCT06955741
Summary
This early-stage study tested a single dose of an experimental antibody drug, BMS-986446, in 46 healthy people. The main goal was to understand how the body processes the drug when given as a shot under the skin versus into a vein, and to check for any side effects. This type of study is a standard first step to gather basic safety and dosing information before testing in people with Alzheimer's disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Anaheim, California, 92801, United States
-
Local Institution - 10000
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.